发明名称 |
COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISEASE |
摘要 |
PROBLEM TO BE SOLVED: To provide a fractalkine (FKN) antibody and a FKN binding fragment of the antibody as a therapeutic drug for inflammatory intestinal diseases with the view that the FKN is induced on the surface of an endothelial cell by inflammation inducing cytokine and is a promising therapeutic target for inflammatory intestinal diseases.SOLUTION: A humanized antibody or a chimeric antibody and a FKN binding fragment thereof binds to FKN comprising CDR-H1, H2, H3, L1, L2 and L3 comprising a specific amino acid sequence. A pharmaceutical composition for inflammatory intestinal diseases comprises the humanized antibody and a FKN binding fragment thereof. Also provided is a therapeutic method therefor. |
申请公布号 |
JP2015027304(A) |
申请公布日期 |
2015.02.12 |
申请号 |
JP20140189668 |
申请日期 |
2014.09.18 |
申请人 |
EISAI R & D MANAGEMENT CO LTD |
发明人 |
NISHIMURA MIYUKI;SAKAMOTO YOSHIMASA;KAWANO TETSU;IMAI TOSHIO |
分类号 |
C12N15/09;A61K31/13;A61K31/135;A61K31/137;A61K31/138;A61K31/165;A61K31/166;A61K31/167;A61K31/192;A61K31/195;A61K31/196;A61K31/197;A61K31/198;A61K31/21;A61K31/27;A61K31/34;A61K31/343;A61K31/357;A61K31/37;A61K31/381;A61K31/4015;A61K31/409;A61K31/4164;A61K31/4168;A61K31/42;A61K31/4365;A61K31/439;A61K31/445;A61K31/4468;A61K31/4525;A61K31/4535;A61K31/454;A61K31/4706;A61K31/485;A61K31/496;A61K31/517;A61K31/519;A61K31/52;A61K31/549;A61K31/55;A61K31/554;A61K31/5575;A61K31/5585;A61K31/56;A61K31/575;A61K31/585;A61K31/592;A61K31/606;A61K31/616;A61K31/64;A61K31/663;A61K31/675;A61K31/7034;A61K31/7056;A61K31/706;A61K31/727;A61K33/06;A61K36/18;A61K38/00;A61K38/21;A61K38/28;A61K38/43;A61K39/395;A61K45/00;A61P1/04;A61P1/16;A61P29/00;A61P37/06;A61P43/00;C07K16/28;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12P21/02 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|